Vaneck Biotech Etf Profile
| BBH Etf | USD 153.65 1.95 1.29% |
|
|
VanEck Biotech is trading at 153.65 as of the 3rd of December 2023. This is a 1.29 percent up since the beginning of the trading day. The etf's open price was 151.7. VanEck Biotech has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for VanEck Biotech ETF are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 18th of December 2020 and ending today, the 3rd of December 2023. Click here to learn more.
The fund normally invests at least 80 percent of its total assets in securities that comprise the funds benchmark index. Vaneck Biotech is traded on NASDAQ Exchange in the United States. More on VanEck Biotech ETF
Moving together with VanEck Etf
| + | 0.88 | XLV | Health Care Select | PairCorr | ||
| + | 0.91 | VHT | Vanguard Health Care | PairCorr | ||
| + | 0.99 | IBB | IShares Biotechnology ETF | PairCorr | ||
| + | 0.84 | XBI | SPDR SP Biotech | PairCorr | ||
| + | 0.7 | IHI | IShares US Medical | PairCorr | ||
| + | 0.9 | IXJ | IShares Global Healthcare | PairCorr | ||
| + | 0.92 | IYH | IShares US Healthcare | PairCorr |
Moving against VanEck Etf
VanEck Etf Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. VanEck Biotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding VanEck Biotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | Philip Hornig |
| Thematic Ideas | (View all Themes) |
| Old Names | [Deutsche Balaton AG, Deutsche Balaton AG, Deutsche Balaton AG, Deutsche Balaton AG, Deutsche Balaton AG, VanEck Biotech ETF] |
| Business Concentration | Sector ETFs, Health Care ETFs (View all Sectors) |
| Macroaxis Advice The buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of VanEck Biotech's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details | |
| Issuer | Van Eck |
| Inception Date | 2011-12-20 |
| Benchmark | Market Vectors US Listed Biotech 25 Index |
| Entity Type | Regulated Investment Company |
| Asset Under Management | 444.61 Million |
| Average Trading Valume | 11,320.4 |
| Asset Type | Equity |
| Category | Sector |
| Focus | Health Care |
| Market Concentration | Developed Markets |
| Region | Global |
| Administrator | Van Eck Associates Corporation |
| Advisor | Van Eck Associates Corporation |
| Custodian | State Street Bank and Trust Company |
| Distributor | Van Eck Securities Corporation |
| Portfolio Manager | Hao-Hung Peter Liao, Guo Hua Jason Jin |
| Transfer Agent | State Street Bank and Trust Company |
| Fiscal Year End | 31-Oct |
| Exchange | NASDAQ |
| Number of Constituents | 25.0 |
| Market Maker | Virtu Financial |
| Total Expense | 0.35 |
| Management Fee | 0.35 |
| Country Name | USA |
| Returns Y T D | (3.81) |
| Name | VanEck Biotech ETF |
| Currency Code | USD |
| Open Figi | BBG000C1FW33 |
| In Threey Volatility | 19.81 |
| 1y Volatility | 15.49 |
| 200 Day M A | 157.57 |
| 50 Day M A | 151.76 |
| Code | BBH |
| Updated At | 2nd of December 2023 |
| Currency Name | US Dollar |
VanEck Biotech ETF [BBH] is traded in USA and was established 2011-12-20. The fund is classified under Health category within VanEck family. The entity is thematically classified as Sector ETFs. VanEck Biotech ETF currently have 478.42 M in assets under management (AUM). , while the total return for the last 3 years was -2.6%.
Check VanEck Biotech Probability Of Bankruptcy
Geographic Allocation (%)
Top VanEck Biotech ETF Etf Constituents
| BGNE | BeiGene | Stock | Health Care |
| ILMN | Illumina | Stock | Health Care |
| VRTX | Vertex Pharmaceuticals | Stock | Health Care |
| SGEN | Seagen Inc | Stock | Health Care |
| REGN | Regeneron Pharmaceuticals | Stock | Health Care |
| NVAX | Novavax | Stock | Health Care |
| MRNA | Moderna | Stock | Health Care |
VanEck Biotech Target Price Odds Analysis
Coming from a normal probability distribution, the odds of VanEck Biotech jumping above the current price in 90 days from now is about 52.73%. The VanEck Biotech ETF probability density function shows the probability of VanEck Biotech etf to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon the etf has a beta coefficient of 1.0061 suggesting VanEck Biotech ETF market returns are responsive to returns on the market. As the market goes up or down, VanEck Biotech is expected to follow. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. VanEck Biotech ETF is significantly underperforming NYSE Composite.
Based on a normal probability distribution, the odds of VanEck Biotech to move above the current price in 90 days from now is about 52.73 (This VanEck Biotech ETF probability density function shows the probability of VanEck Etf to fall within a particular range of prices over 90 days) .
VanEck Biotech Major Institutional Holders
Institutional Holdings refers to the ownership stake in VanEck Biotech that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of VanEck Biotech's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing VanEck Biotech's value.| Instituion | Last Transaction | Type | Shares | Value | |
| Miller Investment Management Lp | 2023-09-30 | Fund Units | 175.6 K | 27.4 M | |
| Goldman Sachs Group Inc | 2023-09-30 | Fund Units | 114 K | 17.7 M | |
| Morgan Stanley | 2023-09-30 | Fund Units | 67.3 K | 10.5 M | |
| Jpmorgan Chase Co | 2023-09-30 | Fund Units | 59.5 K | 9.3 M | |
| Bank Of America Corp | 2023-09-30 | Fund Units | 53.3 K | 8.3 M | |
| Lpl Financial Llc | 2023-09-30 | Fund Units | 43.1 K | 6.7 M | |
| Mogy Joel R Investment Counsel Inc | 2023-06-30 | Fund Units | 36.9 K | 5.8 M | |
| Consolidated Investment Group Llc | 2023-09-30 | Fund Units | 29.7 K | 4.6 M | |
| Commonwealth Equity Services Llc | 2023-09-30 | Fund Units | 28.7 K | 4.5 M | |
| Ubs Group Ag | 2023-09-30 | Fund Units | 27.1 K | 4.2 M | |
| Royal Bank Of Canada | 2023-09-30 | Fund Units | 24.8 K | 3.9 M |
VanEck Biotech ETF Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. VanEck Biotech market risk premium is the additional return an investor will receive from holding VanEck Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in VanEck Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although VanEck Biotech's alpha and beta are two of the key measurements used to evaluate VanEck Biotech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.805 | |||
| Standard Deviation | 1.03 | |||
| Variance | 1.07 | |||
| Risk Adjusted Performance | (0.08) |
VanEck Biotech ETF Technical Analysis
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. VanEck Biotech ETF Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe VanEck Biotech price patterns..
VanEck Biotech Against Markets
Picking the right benchmark for VanEck Biotech etf is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in VanEck Biotech etf price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for VanEck Biotech is critical whether you are bullish or bearish towards VanEck Biotech ETF at a given time. Please also check how VanEck Biotech's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in VanEck Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Premium Stories Now
Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
| All Next | Launch Module |
How to buy VanEck Etf?
Before investing in VanEck Biotech, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in VanEck Biotech. To buy VanEck Biotech etf, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of VanEck Biotech. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase VanEck Biotech etf. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located VanEck Biotech ETF etf in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased VanEck Biotech ETF etf, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the etf
It's important to note that investing in stocks, such as VanEck Biotech ETF, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in etf prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy VanEck Etf please use our How to Invest in VanEck Biotech guide.
Already Invested in VanEck Biotech ETF?
The danger of trading VanEck Biotech ETF is mainly related to its market volatility and ETF specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of VanEck Biotech is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than VanEck Biotech. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile VanEck Biotech ETF is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether VanEck Biotech ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Biotech Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Biotech Etf: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in VanEck Biotech ETF. Also, note that the market value of any ETF could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the VanEck Biotech ETF information on this page should be used as a complementary analysis to other VanEck Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for VanEck Etf analysis
When running VanEck Biotech's price analysis, check to measure VanEck Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VanEck Biotech is operating at the current time. Most of VanEck Biotech's value examination focuses on studying past and present price action to predict the probability of VanEck Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VanEck Biotech's price. Additionally, you may evaluate how the addition of VanEck Biotech to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |
The market value of VanEck Biotech ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Biotech's value that differs from its market value or its book value, called intrinsic value, which is VanEck Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Biotech's market value can be influenced by many factors that don't directly affect VanEck Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.